Pan Drugs Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials and compliance.
CIN U24230GJ1993PLC020671 Incorporated 16 November 1993 ROC Ahmedabad HQ Vadodara, Gujarat, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.12 Cr
▼ 19.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹5.5 Cr
Registered with MCA
Paid-up capital
₹3.14 Cr
Issued & subscribed
Open charges
₹28.43 Lakh
Satisfied ₹45.08 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
34
Latest available

About Pan Drugs Limited

Data last updated: 23 February 2026

Pan Drugs Limited is a public limited company based in Vadodara, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 16 November 1993, the company has been in operation for over 33 years.

Registered with ROC Ahmedabad under CIN L24230GJ1993PLC020671.

Capital: an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹3.14 Cr. It is led by directors including Atul Natwarlal Pandya and Parag Vamanray Raval.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 301 312 World Trade Center Sayajigunj, Vadodara, Gujarat, India – 390007.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.12 Cr, a decline of 19% compared to the previous year.

The company has a workforce of approximately 34 employees as per the latest available data.

The company is associated with 1 brand - Pan Drugs. As per MCA filings, the company has open charges of ₹28.43 Lakh and satisfied charges of ₹45.08 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pandrugsltd.com.

Company Details of Pan Drugs Limited
CIN U24230GJ1993PLC020671
Registration Number 020671
Incorporation Date 16 November 1993
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    301 312 World Trade Center Sayajigunj, Vadodara, Gujarat, India – 390007
  • Industry
    Pharma, Drug Formulation & Development, API Manufacturers
Company report
Pan Drugs Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Pan Drugs Limited report

Financials, compliance, directors, charges, ownership and filings for Pan Drugs Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Pan Drugs Limited

Pan Drugs Limited has one previous CIN (Corporate Identification Number): L24230GJ1993PLC020671. The current CIN is U24230GJ1993PLC020671, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24230GJ1993PLC020671 Current
L24230GJ1993PLC020671 Previous

Associated Brands with Pan Drugs Limited

Pan Drugs Limited operates one associated brand: Pan Drugs. These brands represent Pan Drugs Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures generic Active Pharmaceutical Ingredients and offers contract services worldwide. pandrugsltd.com

Competitors & Alternatives of Pan Drugs Limited

Brands and companies operating in the same space as Pan Drugs Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Pan Drugs Limited

Pan Drugs Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Pan Drugs Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Pan Drugs Limited

Pan Drugs Limited is currently managed by 5 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Atul Natwarlal Pandya Director 31 Jul 2007 19 Years 0 Months Current
Parag Vamanray Raval Director 10 May 2018 8 Years 3 Months Current
Kamal Natwarlal Pandya Director 16 Nov 1993 32 Years 9 Months Current
Hemant Gajanand Upadhyay Director 31 May 2003 23 Years 2 Months Current
Rushiraj Atulbhai Pandya Additional Director 10 Mar 2025 1 Years 5 Months Current

Financials of Pan Drugs Limited FY 2025 filings available

Pan Drugs Limited reported revenue of ₹1.12 Cr (down 19.00% YoY) for FY 2025.

Revenue · FY 2025
₹1.12 Cr ▼ 19.00%
Premium access

Ten-year financial statements for Pan Drugs Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Pan Drugs Limited

Open charges
₹28.43 Lakh
Satisfied charges
₹45.08 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹0.28 Cr
Latest charge details
DateLenderAmountStatus
31 Dec 2021 Hdfc Bank Limited ₹28.43 Lakh Open
20 Oct 2001 State Band of Hydrabad ₹3 Cr Satisfied
13 Sep 2000 Anyonya Co - Operative Bank Ltd. ₹1 Cr Satisfied
31 Mar 2000 Idbi Bank Ltd. ₹11 Cr Satisfied
03 Dec 1999 Idbi Bank Ltd. ₹8.5 Cr Satisfied

Total charge records: 13 View all charges

Employees and EPFO Compliance at Pan Drugs Limited

View historical data on people associated with Pan Drugs Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Pan Drugs Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Pan Drugs Limited

Premium access

GST registrations and filing compliance for Pan Drugs Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Pan Drugs Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Pan Drugs Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Pan Drugs Limited

Premium access

MSME payment history for Pan Drugs Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Pan Drugs Limited

Premium access

Corporate group structure for Pan Drugs Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Pan Drugs Limited

Premium access

MCA filings and documents for Pan Drugs Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Pan Drugs Limited

Activity
30 Sep 2025
Pan Drugs Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Pan Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
10 Mar 2025
Rushiraj Atulbhai Pandya was appointed as a Additional Director on 10 Mar 2025 & has been associated with this company since 1 year 5 months.
Charges
31 Dec 2021
A charge with Hdfc Bank Limited amounted to Rs. 0.28 Cr with Charge ID 100527683 was registered on 31 Dec 2021.
Charges
23 Jan 2020
A charge registered on 13 Sep 2000 via Charge ID 90099257 with Anyonya Co - Operative Bank Ltd. was fully satisfied on 23 Jan 2020.
Charges
23 Jan 2020
A charge registered on 15 Oct 1998 via Charge ID 90096565 with Anyonya Sahakari Mandli Co - Op. Bank Ltd. was fully satisfied on 23 Jan 2020.

Frequently Asked Questions about Pan Drugs Limited

Pan Drugs Limited is an active public limited company in the pharma sector based in Vadodara, Gujarat, India. It was incorporated on 16 November 1993 (33+ years old) and is registered under CIN U24230GJ1993PLC020671. The company has 34 employees.

Pan Drugs Limited reported revenue of ₹1.12 Cr for FY 2025 (down 19.00% YoY).

The current directors of Pan Drugs Limited are:

The primary industry of Pan Drugs Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Pan Drugs Limited can be reached at the registered office: 301 312 World Trade Center Sayajigunj, Vadodara, Gujarat, India – 390007, or through the website pandrugsltd.com.

The authorised capital is ₹5.5 Cr, and the paid-up capital is ₹3.14 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available